KIT and gastrointestinal stromal tumor: Oncogenic mutations in the stem cell factor receptor tyrosine kinase (cKIT) or the platelet-derived growth factor receptor alpha (PDGFRA) are found in 85–90% of patients with gastrointestinal stromal tumors (GISTs) [1].